Señales en vivo de CRGX | Maximiza tus Ganancias con Getagraph.com

COMPRAR 136760 min ago

@ $21.56

Emitido: 14 feb 2024 @ 14:23

Retorno: -5.27%

Señal anterior: feb 14 - 09:30

Señal anterior: Vender

Retorno: -1.98 %

Live Chart Being Loaded With Signals

Commentary (17 may 2024 @ 16:00):

Stats
Volumen de hoy	148 859
Volumen promedio	308 920
Capitalización de mercado	804.06M
EPS	$0 ( 2024-03-27 )
Próxima fecha de ganancias	( $-1.050 ) 2024-06-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0520 (0.25%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-12	Rtw Investments, Lp	Sell	1 842 499	Common stock, par value $0.001 per share ("Common Stock")
2023-11-14	Rtw Investments, Lp	Buy	0	Common stock, par value $0.001 per share
2023-11-14	Perceptive Advisors Llc	Buy	333 333	Common Stock
2023-11-14	Perceptive Advisors Llc	Buy	2 579 502	Common Stock
2023-11-14	Perceptive Advisors Llc	Buy	333 333	Common Stock

INSIDER POWER
-17.52
Last 10 transactions
Buy: 3 296 168 \| Sell: 4 503 291

Volumen Correlación

Largo: -0.13 (neutral)

Corto: -0.11 (neutral)

Signal:(67.505) Neutral

CARGO Therapeutics, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CARGO Therapeutics, Inc. Correlación - Moneda/Commodity

-0.64
( weak negative )

-0.68
( moderate negative )

-0.67
( moderate negative )

-0.48
( neutral )

-0.77
( moderate negative )

-0.23
( neutral )

CARGO Therapeutics, Inc. Finanzas

Annual	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$0

FY	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

CARGO Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

CARGO Therapeutics, Inc.

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.